Report Cover

Anticoagulants Market Size By Drug Class (Factor Xa Inhibitors, Heparin, Warfarin, Direct Thrombin Inhibitors), By Route of Administration (Oral, Injectables), By Application (Venous Thromboembolism, Atrial Fibrillation/Flutter, Coronary Artery Disease), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027


The anticoagulants market is set to witness exponential growth over the forecast time period due to increased acceptability of newer class of non-vitamin K oral anticoagulants and increasing product usage in coronary artery disease, atrial fibrillation/flutter, and venous thromboembolism among others. Anticoagulants are basically medicines that help in preventing blood from clotting. 

These medicines are given to patients who are at a higher risk of getting blood clots, as well as to decrease their chances of developing any serious conditions like heart attacks and strokes. Anticoagulants generally work by interposing the process that is involved in the blood clots formation. These are also known as blood thinning medicines and are known to be very different from antiplatelet medicines like clopidogrel and low-dose aspirin. 

The anticoagulants market is segmented in terms of drug class, route of administration, application, distribution channel, and regional landscape.

With respect to drug class the market for anticoagulants is classified into direct thrombin inhibitor, warfarin (Vitamin K antagonist), factor Xa inhibitor, heparins, and others. In 2020, the warfarin segment accounted for a market share of 1.8% and is estimated to follow a strong growth trend over the coming years. Vitamin K antagonists help to stop the liver from processing vitamin K into essential factors that usually help in clotting the blood. This further controls blood clotting. 

One of the main advantages of this type of anticoagulant drug class is that it is far easier than other types to reverse in case of sudden bleeding from emergency or trauma surgery.

Based on route of administration the anticoagulants market is divided into injectables and oral. Among these, the oral anticoagulants segment accounted for a valuation of more than $14.2 billion in 2020 and is estimated to foresee lucrative growth over the upcoming years. 

In terms of application the overall anticoagulants market is categorized into coronary artery disease, AF/flutter, venous thromboembolism, and others. Here, the AF (atrial fibrillation)/flutter segment is expected to reach approximately $14.1 billion valuation by the end of 2027. Anticoagulants or blood thinning medicines have been highly recommended to decrease the risk of stroke in patients diagnosed with atrial fibrillation who have higher risk of thromboembolism or/and stroke caused by blocked arteries.
 
With respect to distribution channel, the market is bifurcated into online pharmacy, retail pharmacy, and hospital pharmacy. Hospital pharmacy is projected to exhibit a steady growth rate of 6.0% during the analysis period.

From a regional frame of reference, in 2020, Latin America anticoagulants market accounted for a market share of 1.3% and is estimated to follow a strong growth trend over the coming years. 

Meanwhile the anticoagulants market in Middle East & Africa generated revenue of $372.6 million in 2020 and will continue to follow appreciative growth over the coming years.
Report Content
Chapter 1.  Methodology
1.1. Market definitions
1.2. Base estimates & working
1.2.1.  North America
1.2.2.  Europe
1.2.3.  Asia Pacific
1.2.4.  Latin America
1.2.5.  Middle East & Africa
1.3. Forecast parameters
1.4. Data validation
1.5. Data Sources
1.5.1.  Secondary
1.5.1.1.   Paid sources
1.5.1.2.    Unpaid sources
1.5.2.  Primary
Chapter 2.  Executive Summary
2.1. Anticoagulants industry 360 degree synopsis, 2016-2027
2.1.1.  Business trends
2.1.2.  Drug class trends
2.1.3.  Route of administration trends
2.1.4.  Application trends
2.1.5.  Distribution channel trends
2.1.6.  Regional trends
Chapter 3.  Anticoagulants Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2016 - 2027
3.3. Industry impact forces
3.3.1.  Growth drivers
3.3.1.1. Growing prevalence of chronic disease
3.3.1.2.    Growing adoption of novel oral anticoagulants (NOACs)
3.3.1.3.    Rising geriatric population across the globe
3.3.2.  Industry pitfalls & challenges
3.3.2.1. High risk of side effects
3.3.2.2.    Stringent regulatory framework
3.4. Growth potential analysis
3.4.1.  By drug class
3.4.2.  By route of administration
3.4.3.  By application
3.4.4.  By distribution channel
3.5. COVID-19 impact analysis
3.6. Porter's analysis
3.7. Competitive landscape
3.7.1.  Company matrix analysis, 2019
3.8. PESTEL analysis
Chapter 4.  Anticoagulants Market, By Drug Class
4.1. Key segment trends
4.2. Factor Xa inhibitor
4.2.1.  Market size, by region, 2016 - 2027 (USD Million)
4.3. Heparin
4.3.1.  Market size, by region, 2016 - 2027 (USD Million)
4.4. Warfarin
4.4.1.  Market size, by region, 2016 - 2027 (USD Million)
4.5. Direct thrombin inhibitor
4.5.1.  Market size, by region, 2016 - 2027 (USD Million)
4.6. Others
4.6.1.  Market size, by region, 2016 - 2027 (USD Million)
Chapter 5.  Anticoagulants Market, By Route of Administration 
5.1. Key segment trends
5.2. Oral
5.2.1.  Market size, by region, 2016 - 2027 (USD Million)
5.3. Injectable
5.3.1.  Market size, by region, 2016 - 2027 (USD Million)
Chapter 6.  Anticoagulants Market, By Application
6.1. Key segment trends
6.2. Venous thromboembolism
6.2.1.  Market size, by region, 2016 - 2027 (USD Million)
6.3. Atrial fibrillation/flutter
6.3.1.  Market size, by region, 2016 - 2027 (USD Million)
6.4. Coronary artery disease
6.4.1.  Market size, by region, 2016 - 2027 (USD Million)
6.5. Others
6.5.1.   Market size, by region, 2016 - 2027 (USD Million)
Chapter 7.  Anticoagulants Market, By Distribution Channel  
7.1. Key segment trends
7.2. Hospital pharmacy
7.2.1.  Market size, by region, 2016 - 2027 (USD Million)
7.3. Retail pharmacy
7.3.1.  Market size, by region, 2016 - 2027 (USD Million)
7.4. Online pharmacy
7.4.1.  Market size, by region, 2016 - 2027 (USD Million)
Chapter 8.  Anticoagulants Market, By Region
8.1. Key regional trends
8.2. North America
8.2.1.  Market size, by country, 2016 - 2027 (USD Million)
8.2.2.  Market size, by drug class, 2016 - 2027 (USD Million)
8.2.3.  Market size, by route of administration, 2016 - 2027 (USD Million)
8.2.4.  Market size, by application, 2016 - 2027 (USD Million)
8.2.5.  Market size, by distribution channel, 2016 - 2027 (USD Million)
8.2.6.  U.S.
8.2.6.1.  Market size, by drug class, 2016 - 2027 (USD Million)
8.2.6.2.  Market size, by route of administration, 2016 - 2027 (USD Million)
8.2.6.3.    Market size, by application, 2016 - 2027 (USD Million)
8.2.6.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)
8.2.7.  Canada
8.2.7.1.  Market size, by drug class, 2016 - 2027 (USD Million)
8.2.7.2.  Market size, by route of administration, 2016 - 2027 (USD Million)
8.2.7.3.    Market size, by application, 2016 - 2027 (USD Million)
8.2.7.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)
8.3. Europe        
8.3.1.  Market size, by country, 2016 - 2027 (USD Million)
8.3.2.  Market size, by drug class, 2016 - 2027 (USD Million)
8.3.3.  Market size, by route of administration, 2016 - 2027 (USD Million)
8.3.4.  Market size, by application, 2016 - 2027 (USD Million)
8.3.5.  Market size, by distribution channel, 2016 - 2027 (USD Million)
8.3.6.  Germany
8.3.6.1.  Market size, by drug class, 2016 - 2027 (USD Million)
8.3.6.2.  Market size, by route of administration, 2016 - 2027 (USD Million)
8.3.6.3.    Market size, by application, 2016 - 2027 (USD Million)
8.3.6.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)
8.3.7.  UK
8.3.7.1.  Market size, by drug class, 2016 - 2027 (USD Million)
8.3.7.2.  Market size, by route of administration, 2016 - 2027 (USD Million)
8.3.7.3.    Market size, by application, 2016 - 2027 (USD Million)
8.3.7.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)
8.3.8.  France
8.3.8.1.  Market size, by drug class, 2016 - 2027 (USD Million)
8.3.8.2.  Market size, by route of administration, 2016 - 2027 (USD Million)
8.3.8.3.    Market size, by application, 2016 - 2027 (USD Million)
8.3.8.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)
8.3.9.  Italy
8.3.9.1.  Market size, by drug class, 2016 - 2027 (USD Million)
8.3.9.2.  Market size, by route of administration, 2016 - 2027 (USD Million)
8.3.9.3.    Market size, by application, 2016 - 2027 (USD Million)
8.3.9.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)
8.3.10. Spain
8.3.10.1.  Market size, by drug class, 2016 - 2027 (USD Million)
8.3.10.2.  Market size, by route of administration, 2016 - 2027 (USD Million)
8.3.10.3.  Market size, by application, 2016 - 2027 (USD Million)
8.3.10.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)
8.4. Asia Pacific
8.4.1.  Market size, by country, 2016 - 2027 (USD Million)
8.4.2.  Market size, by drug class, 2016 - 2027 (USD Million)
8.4.3.  Market size, by route of administration, 2016 - 2027 (USD Million)
8.4.4.  Market size, by application, 2016 - 2027 (USD Million)
8.4.5.  Market size, by distribution channel, 2016 - 2027 (USD Million)
8.4.6.  Japan
8.4.6.1.  Market size, by drug class, 2016 - 2027 (USD Million)
8.4.6.2.  Market size, by route of administration, 2016 - 2027 (USD Million)
8.4.6.3.    Market size, by application, 2016 - 2027 (USD Million)
8.4.6.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)
8.4.7.  China
8.4.7.1.  Market size, by drug class, 2016 - 2027 (USD Million)
8.4.7.2.  Market size, by route of administration, 2016 - 2027 (USD Million)
8.4.7.3.    Market size, by application, 2016 - 2027 (USD Million)
8.4.7.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)
8.4.8.  India
8.4.8.1.  Market size, by drug class, 2016 - 2027 (USD Million)
8.4.8.2.  Market size, by route of administration, 2016 - 2027 (USD Million)
8.4.8.3.    Market size, by application, 2016 - 2027 (USD Million)
8.4.8.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)
8.4.9.  Australia
8.4.9.1.  Market size, by drug class, 2016 - 2027 (USD Million)
8.4.9.2.  Market size, by route of administration, 2016 - 2027 (USD Million)
8.4.9.3.    Market size, by application, 2016 - 2027 (USD Million)
8.4.9.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)
8.5. Latin America
8.5.1.  Market size, by country, 2016 - 2027 (USD Million)
8.5.2.  Market size, by drug class, 2016 - 2027 (USD Million)
8.5.3.  Market size, by route of administration, 2016 - 2027 (USD Million)
8.5.4.  Market size, by application, 2016 - 2027 (USD Million)
8.5.5.  Market size, by distribution channel, 2016 - 2027 (USD Million)
8.5.6.  Brazil
8.5.6.1.  Market size, by drug class, 2016 - 2027 (USD Million)
8.5.6.2.  Market size, by route of administration, 2016 - 2027 (USD Million)
8.5.6.3.    Market size, by application, 2016 - 2027 (USD Million)
8.5.6.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)
8.5.7.  Mexico
8.5.7.1.  Market size, by drug class, 2016 - 2027 (USD Million)
8.5.7.2.  Market size, by route of administration, 2016 - 2027 (USD Million)
8.5.7.3.    Market size, by application, 2016 - 2027 (USD Million)
8.5.7.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)
8.5.8.  Argentina
8.5.8.1.  Market size, by drug class, 2016 - 2027 (USD Million)
8.5.8.2.  Market size, by route of administration, 2016 - 2027 (USD Million)
8.5.8.3.    Market size, by application, 2016 - 2027 (USD Million)
8.5.8.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)
8.6. MEA
8.6.1.  Market size, by country, 2016 - 2027 (USD Million)
8.6.2.  Market size, by drug class, 2016 - 2027 (USD Million)
8.6.3.  Market size, by route of administration, 2016 - 2027 (USD Million)
8.6.4.  Market size, by application, 2016 - 2027 (USD Million)
8.6.5.  Market size, by distribution channel, 2016 - 2027 (USD Million)
8.6.6.  South Africa
8.6.6.1.  Market size, by drug class, 2016 - 2027 (USD Million)
8.6.6.2.  Market size, by route of administration, 2016 - 2027 (USD Million)
8.6.6.3.    Market size, by application, 2016 - 2027 (USD Million)
8.6.6.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)
8.6.7.  Saudi Arabia
8.6.7.1.  Market size, by drug class, 2016 - 2027 (USD Million)
8.6.7.2.  Market size, by route of administration, 2016 - 2027 (USD Million)
8.6.7.3.    Market size, by application, 2016 - 2027 (USD Million)
8.6.7.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)
8.6.8.  UAE
8.6.8.1.  Market size, by drug class, 2016 - 2027 (USD Million)
8.6.8.2.  Market size, by route of administration, 2016 - 2027 (USD Million)
8.6.8.3.    Market size, by application, 2016 - 2027 (USD Million)
8.6.8.4.  Market size, by distribution channel, 2016 - 2027 (USD Million)
Chapter 9.  Company Profiles
9.1. Competitive dashboard, 2019
9.2. Bristol-Myers Squibb Company
9.2.1.  Business overview
9.2.2.  Financial data
9.2.3.  Product landscape
9.2.4.  Strategic outlook
9.2.5.  SWOT analysis
9.3. Bayer AG
9.3.1.  Business overview
9.3.2.  Financial data
9.3.3.  Product landscape
9.3.4.  Strategic outlook
9.3.5.  SWOT analysis
9.4. Boehringer Ingelheim
9.4.1.   Business overview
9.4.2.  Financial data
9.4.3.  Product landscape
9.4.4.  Strategic outlook
9.4.5.  SWOT analysis
9.5. Johnson and Johnson
9.5.1.    Business overview
9.5.2.  Financial data
9.5.3.  Product landscape
9.5.4.  Strategic outlook
9.5.5.  SWOT analysis
9.6. DAIICHI SANKYO COMPANY
9.6.1.  Business overview
9.6.2.  Financial data
9.6.3.  Product landscape
9.6.4.  Strategic outlook
9.6.5.  SWOT analysis
9.7. Portola Pharmaceutical
9.7.1.  Business overview
9.7.2.  Financial data
9.7.3.  Product landscape
9.7.4.  Strategic outlook
9.7.5.  SWOT analysis
9.8. Amphastar
9.8.1.  Business overview
9.8.2.  Financial data
9.8.3.  Product landscape
9.8.4.  Strategic outlook
9.8.5.  SWOT analysis
9.9. Leo Pharma
9.9.1.  Business overview
9.9.2.  Financial data
9.9.3.  Product landscape
9.9.4.  Strategic outlook
9.9.5.  SWOT analysis
9.10.  United Therapeutics
9.10.1.  Business overview
9.10.2.    Financial data
9.10.3.    Product landscape
9.10.4.    Strategic outlook
9.10.5.    SWOT analysis
9.11.  Pfizer
9.11.1.  Business overview
9.11.2.    Financial data
9.11.3.    Product landscape
9.11.4.    Strategic outlook
9.11.5.    SWOT analysis
9.12.  Rovi
9.12.1.  Business overview
9.12.2.    Financial data
9.12.3.    Product landscape
9.12.4.    Strategic outlook
9.12.5.    SWOT analysis
9.13.  Sanofi
9.13.1.  Business overview
9.13.2.    Financial data
9.13.3.    Product landscape
9.13.4.    Strategic outlook
9.13.5.    SWOT analysis
9.14.  Shenzhen Hepalink
9.14.1.  Business overview
9.14.2.    Financial data
9.14.3.    Product landscape
9.14.4.    Strategic outlook
9.14.5.    SWOT analysis

Data Tables TABLE 1 Anticoagulants industry 360 degree synopsis, 2016 - 2027 TABLE 2 Global anticoagulants market, 2016 - 2020 (USD Million) TABLE 3 Global anticoagulants market, 2021 - 2027 (USD Million) TABLE 4 Global anticoagulants market, by drug class, 2016 - 2020 (USD Million) TABLE 5 Global anticoagulants market, by drug class, 2021 - 2027 (USD Million) TABLE 6 Global anticoagulants market, by route of administration, 2016 - 2020 (USD Million) TABLE 7 Global anticoagulants market, by route of administration, 2021 - 2027 (USD Million) TABLE 8 Global anticoagulants market, by application, 2016 - 2020 (USD Million) TABLE 9 Global anticoagulants market, by application, 2021 - 2027 (USD Million) TABLE 10 Global anticoagulants market, by distribution channel, 2016 - 2020 (USD Million) TABLE 11 Global anticoagulants market, by distribution channel, 2021 - 2027 (USD Million) TABLE 12 Global anticoagulants market, by region, 2016 - 2020 (USD Million) TABLE 13 Global anticoagulants market, by region, 2021 - 2027 (USD Million) TABLE 14 Industry impact forces TABLE 15 Factor Xa inhibitors market size, by region, 2016 - 2020 (USD Million) TABLE 16 Factor Xa inhibitors market size, by region, 2021 - 2027 (USD Million) TABLE 17 Heparin market size, by region, 2016 - 2020 (USD Million) TABLE 18 Heparin market size, by region, 2021 - 2027 (USD Million) TABLE 19 Warfarin market size, by region, 2016 - 2020 (USD Million) TABLE 20 Warfarin market size, by region, 2021 - 2027 (USD Million) TABLE 21 Direct thrombin inhibitors market size, by region, 2016 - 2020 (USD Million) TABLE 22 Direct thrombin inhibitors market size, by region, 2021 - 2027 (USD Million) TABLE 23 Others market size, by region, 2016 - 2020 (USD Million) TABLE 24 Others market size, by region, 2021 - 2027 (USD Million) TABLE 25 Oral market size, by region, 2016 - 2020 (USD Million) TABLE 26 Oral market size, by region, 2021 - 2027 (USD Million) TABLE 27 Injectable market size, by region, 2016 - 2020 (USD Million) TABLE 28 Injectable market size, by region, 2021 - 2027 (USD Million) TABLE 29 Venous thromboembolism market size, by region, 2016 - 2020 (USD Million) TABLE 30 Venous thromboembolism market size, by region, 2021 - 2027 (USD Million) TABLE 31 Atrial fibrillation/flutter market size, by region, 2016 - 2020 (USD Million) TABLE 32 Atrial fibrillation/flutter market size, by region, 2021 - 2027 (USD Million) TABLE 33 Coronary artery disease market size, by region, 2016 - 2020 (USD Million) TABLE 34 Coronary artery disease market size, by region, 2021 - 2027 (USD Million) TABLE 35 Others market size, by region, 2016 - 2020 (USD Million) TABLE 36 Others market size, by region, 2021 - 2027 (USD Million) TABLE 37 Hospital pharmacy market size, by region, 2016 - 2020 (USD Million) TABLE 38 Hospital pharmacy market size, by region, 2021 - 2027 (USD Million) TABLE 39 Retail pharmacy market size, by region, 2016 - 2020 (USD Million) TABLE 40 Retail pharmacy market size, by region, 2021 - 2027 (USD Million) TABLE 41 Online pharmacy market size, by region, 2016 - 2020 (USD Million) TABLE 42 Online pharmacy market size, by region, 2021 - 2027 (USD Million) TABLE 43 North America anticoagulants market size, by country, 2016 - 2020 (USD Million) TABLE 44 North America anticoagulants market size, by country, 2021 - 2027 (USD Million) TABLE 45 North America anticoagulants market size, by drug class, 2016 - 2020 (USD Million) TABLE 46 North America anticoagulants market size, by drug class, 2021 - 2027 (USD Million) TABLE 47 North America anticoagulants market size, by route of administration, 2016 - 2020 (USD Million) TABLE 48 North America anticoagulants market size, by route of administration, 2021 - 2027 (USD Million) TABLE 49 North America anticoagulants market size, by application, 2016 - 2020 (USD Million) TABLE 50 North America anticoagulants market size, by application, 2021 - 2027 (USD Million) TABLE 51 North America anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million) TABLE 52 North America anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million) TABLE 53 U.S. anticoagulants market size, by drug class, 2016 - 2020 (USD Million) TABLE 54 U.S. anticoagulants market size, by drug class, 2021 - 2027 (USD Million) TABLE 55 U.S. anticoagulants market size, by route of administration, 2016 - 2020 (USD Million) TABLE 56 U.S. anticoagulants market size, by route of administration, 2021 - 2027 (USD Million) TABLE 57 U.S. anticoagulants market size, by application, 2016 - 2020 (USD Million) TABLE 58 U.S. anticoagulants market size, by application, 2021 - 2027 (USD Million) TABLE 59 U.S. anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million) TABLE 60 U.S. anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million) TABLE 61 Canada anticoagulants market size, by drug class, 2016 - 2020 (USD Million) TABLE 62 Canada anticoagulants market size, by drug class, 2021 - 2027 (USD Million) TABLE 63 Canada anticoagulants market size, by route of administration, 2016 - 2020 (USD Million) TABLE 64 Canada anticoagulants market size, by route of administration, 2021 - 2027 (USD Million) TABLE 65 Canada anticoagulants market size, by application, 2016 - 2020 (USD Million) TABLE 66 Canada anticoagulants market size, by application, 2021 - 2027 (USD Million) TABLE 67 Canada anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million) TABLE 68 Canada anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million) TABLE 69 Europe anticoagulants market size, by country, 2016 - 2020 (USD Million) TABLE 70 Europe anticoagulants market size, by country, 2021 - 2027 (USD Million) TABLE 71 Europe anticoagulants market size, by drug class, 2016 - 2020 (USD Million) TABLE 72 Europe anticoagulants market size, by drug class, 2021 - 2027 (USD Million) TABLE 73 Europe anticoagulants market size, by route of administration, 2016 - 2020 (USD Million) TABLE 74 Europe anticoagulants market size, by route of administration, 2021 - 2027 (USD Million) TABLE 75 Europe anticoagulants market size, by application, 2016 - 2020 (USD Million) TABLE 76 Europe anticoagulants market size, by application, 2021 - 2027 (USD Million) TABLE 77 Europe anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million) TABLE 78 Europe anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million) TABLE 79 Germany anticoagulants market size, by drug class, 2016 - 2020 (USD Million) TABLE 80 Germany anticoagulants market size, by drug class, 2021 - 2027 (USD Million) TABLE 81 Germany anticoagulants market size, by route of administration, 2016 - 2020 (USD Million) TABLE 82 Germany anticoagulants market size, by route of administration, 2021 - 2027 (USD Million) TABLE 83 Germany anticoagulants market size, by application, 2016 - 2020 (USD Million) TABLE 84 Germany anticoagulants market size, by application, 2021 - 2027 (USD Million) TABLE 85 Germany anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million) TABLE 86 Germany anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million) TABLE 87 UK anticoagulants market size, by drug class, 2016 - 2020 (USD Million) TABLE 88 UK anticoagulants market size, by drug class, 2021 - 2027 (USD Million) TABLE 89 UK anticoagulants market size, by route of administration, 2016 - 2020 (USD Million) TABLE 90 UK anticoagulants market size, by route of administration, 2021 - 2027 (USD Million) TABLE 91 UK anticoagulants market size, by application, 2016 - 2020 (USD Million) TABLE 92 UK anticoagulants market size, by application, 2021 - 2027 (USD Million) TABLE 93 UK anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million) TABLE 94 UK anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million) TABLE 95 France anticoagulants market size, by drug class, 2016 - 2020 (USD Million) TABLE 96 France anticoagulants market size, by drug class, 2021 - 2027 (USD Million) TABLE 97 France anticoagulants market size, by route of administration, 2016 - 2020 (USD Million) TABLE 98 France anticoagulants market size, by route of administration, 2021 - 2027 (USD Million) TABLE 99 France anticoagulants market size, by application, 2016 - 2020 (USD Million) TABLE 100 France anticoagulants market size, by application, 2021 - 2027 (USD Million) TABLE 101 France anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million) TABLE 102 France anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million) TABLE 103 Italy anticoagulants market size, by drug class, 2016 - 2020 (USD Million) TABLE 104 Italy anticoagulants market size, by drug class, 2021 - 2027 (USD Million) TABLE 105 Italy anticoagulants market size, by route of administration, 2016 - 2020 (USD Million) TABLE 106 Italy anticoagulants market size, by route of administration, 2021 - 2027 (USD Million) TABLE 107 Italy anticoagulants market size, by application, 2016 - 2020 (USD Million) TABLE 108 Italy anticoagulants market size, by application, 2021 - 2027 (USD Million) TABLE 109 Italy anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million) TABLE 110 Italy anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million) TABLE 111 Spain anticoagulants market size, by drug class, 2016 - 2020 (USD Million) TABLE 112 Spain anticoagulants market size, by drug class, 2021 - 2027 (USD Million) TABLE 113 Spain anticoagulants market size, by route of administration, 2016 - 2020 (USD Million) TABLE 114 Spain anticoagulants market size, by route of administration, 2021 - 2027 (USD Million) TABLE 115 Spain anticoagulants market size, by source, 2021 - 2027 (USD Million) TABLE 116 Spain anticoagulants market size, by application, 2016 - 2020 (USD Million) TABLE 117 Spain anticoagulants market size, by application, 2021 - 2027 (USD Million) TABLE 118 Spain anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million) TABLE 119 Spain anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million) TABLE 120 Asia Pacific anticoagulants market size, by country, 2016 - 2020 (USD Million) TABLE 121 Asia Pacific anticoagulants market size, by country, 2021 - 2027 (USD Million) TABLE 122 Asia Pacific anticoagulants market size, by drug class, 2016 - 2020 (USD Million) TABLE 123 Asia Pacific anticoagulants market size, by drug class, 2021 - 2027 (USD Million) TABLE 124 Asia Pacific anticoagulants market size, by route of administration, 2016 - 2020 (USD Million) TABLE 125 Asia Pacific anticoagulants market size, by route of administration, 2021 - 2027 (USD Million) TABLE 126 Asia Pacific anticoagulants market size, by application, 2016 - 2020 (USD Million) TABLE 127 Asia Pacific anticoagulants market size, by application, 2021 - 2027 (USD Million) TABLE 128 Asia Pacific anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million) TABLE 129 Asia Pacific anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million) TABLE 130 China anticoagulants market size, by drug class, 2016 - 2020 (USD Million) TABLE 131 China anticoagulants market size, by drug class, 2021 - 2027 (USD Million) TABLE 132 China anticoagulants market size, by route of administration, 2016 - 2020 (USD Million) TABLE 133 China anticoagulants market size, by route of administration, 2021 - 2027 (USD Million) TABLE 134 China anticoagulants market size, by application, 2016 - 2020 (USD Million) TABLE 135 China anticoagulants market size, by application, 2021 - 2027 (USD Million) TABLE 136 China anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million) TABLE 137 China anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million) TABLE 138 Japan anticoagulants market size, by drug class, 2016 - 2020 (USD Million) TABLE 139 Japan anticoagulants market size, by drug class, 2021 - 2027 (USD Million) TABLE 140 Japan anticoagulants market size, by route of administration, 2016 - 2020 (USD Million) TABLE 141 Japan anticoagulants market size, by route of administration, 2021 - 2027 (USD Million) TABLE 142 Japan anticoagulants market size, by application, 2016 - 2020 (USD Million) TABLE 143 Japan anticoagulants market size, by application, 2021 - 2027 (USD Million) TABLE 144 Japan anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million) TABLE 145 Japan anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million) TABLE 146 India anticoagulants market size, by drug class, 2016 - 2020 (USD Million) TABLE 147 India anticoagulants market size, by drug class, 2021 - 2027 (USD Million) TABLE 148 India anticoagulants market size, by route of administration, 2016 - 2020 (USD Million) TABLE 149 India anticoagulants market size, by route of administration, 2021 - 2027 (USD Million) TABLE 150 India anticoagulants market size, by application, 2016 - 2020 (USD Million) TABLE 151 India anticoagulants market size, by application, 2021 - 2027 (USD Million) TABLE 152 India anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million) TABLE 153 India anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million) TABLE 154 Australia anticoagulants market size, by drug class, 2016 - 2020 (USD Million) TABLE 155 Australia anticoagulants market size, by drug class, 2021 - 2027 (USD Million) TABLE 156 Australia anticoagulants market size, by route of administration, 2016 - 2020 (USD Million) TABLE 157 Australia anticoagulants market size, by route of administration, 2021 - 2027 (USD Million) TABLE 158 Australia anticoagulants market size, by application, 2016 - 2020 (USD Million) TABLE 159 Australia anticoagulants market size, by application, 2021 - 2027 (USD Million) TABLE 160 Australia anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million) TABLE 161 Australia anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million) TABLE 162 Latin America anticoagulants market size, by country, 2016 - 2020 (USD Million) TABLE 163 Latin America anticoagulants market size, by country, 2021 - 2027 (USD Million) TABLE 164 Latin America anticoagulants market size, by drug class, 2016 - 2020 (USD Million) TABLE 165 Latin America anticoagulants market size, by drug class, 2021 - 2027 (USD Million) TABLE 166 Latin America anticoagulants market size, by route of administration, 2016 - 2020 (USD Million) TABLE 167 Latin America anticoagulants market size, by route of administration, 2021 - 2027 (USD Million) TABLE 168 Latin America anticoagulants market size, by application, 2016 - 2020 (USD Million) TABLE 169 Latin America anticoagulants market size, by application, 2021 - 2027 (USD Million) TABLE 170 Latin America anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million) TABLE 171 Latin America anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million) TABLE 172 Brazil anticoagulants market size, by drug class, 2016 - 2020 (USD Million) TABLE 173 Brazil anticoagulants market size, by drug class, 2021 - 2027 (USD Million) TABLE 174 Brazil anticoagulants market size, by route of administration, 2016 - 2020 (USD Million) TABLE 175 Brazil anticoagulants market size, by route of administration, 2021 - 2027 (USD Million) TABLE 176 Brazil anticoagulants market size, by application, 2016 - 2020 (USD Million) TABLE 177 Brazil anticoagulants market size, by application, 2021 - 2027 (USD Million) TABLE 178 Brazil anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million) TABLE 179 Brazil anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million) TABLE 180 Mexico anticoagulants market size, by drug class, 2016 - 2020 (USD Million) TABLE 181 Mexico anticoagulants market size, by drug class, 2021 - 2027 (USD Million) TABLE 182 Mexico anticoagulants market size, by route of administration, 2016 - 2020 (USD Million) TABLE 183 Mexico anticoagulants market size, by route of administration, 2021 - 2027 (USD Million) TABLE 184 Mexico anticoagulants market size, by application, 2016 - 2020 (USD Million) TABLE 185 Mexico anticoagulants market size, by application, 2021 - 2027 (USD Million) TABLE 186 Mexico anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million) TABLE 187 Mexico anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million) TABLE 188 Argentina anticoagulants market size, by drug class, 2016 - 2020 (USD Million) TABLE 189 Argentina anticoagulants market size, by drug class, 2021 - 2027 (USD Million) TABLE 190 Argentina anticoagulants market size, by route of administration, 2016 - 2020 (USD Million) TABLE 191 Argentina anticoagulants market size, by route of administration, 2021 - 2027 (USD Million) TABLE 192 Argentina anticoagulants market size, by application, 2016 - 2020 (USD Million) TABLE 193 Argentina anticoagulants market size, by application, 2021 - 2027 (USD Million) TABLE 194 Argentina anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million) TABLE 195 Argentina anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million) TABLE 196 MEA anticoagulants market size, by country, 2016 - 2020 (USD Million) TABLE 197 MEA anticoagulants market size, by country, 2021 - 2027 (USD Million) TABLE 198 MEA anticoagulants market size, by drug class, 2016 - 2020 (USD Million) TABLE 199 MEA anticoagulants market size, by drug class, 2021 - 2027 (USD Million) TABLE 200 MEA anticoagulants market size, by route of administration, 2016 - 2020 (USD Million) TABLE 201 MEA anticoagulants market size, by route of administration, 2021 - 2027 (USD Million) TABLE 202 MEA anticoagulants market size, by application, 2016 - 2020 (USD Million) TABLE 203 MEA anticoagulants market size, by application, 2021 - 2027 (USD Million) TABLE 204 MEA anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million) TABLE 205 MEA anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million) TABLE 206 South Africa anticoagulants market size, by drug class, 2016 - 2020 (USD Million) TABLE 207 South Africa anticoagulants market size, by drug class, 2021 - 2027 (USD Million) TABLE 208 South Africa anticoagulants market size, by route of administration, 2016 - 2020 (USD Million) TABLE 209 South Africa anticoagulants market size, by route of administration, 2021 - 2027 (USD Million) TABLE 210 South Africa anticoagulants market size, by application, 2016 - 2020 (USD Million) TABLE 211 South Africa anticoagulants market size, by application, 2021 - 2027 (USD Million) TABLE 212 South Africa anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million) TABLE 213 South Africa anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million) TABLE 214 Saudi Arabia anticoagulants market size, by drug class, 2016 - 2020 (USD Million) TABLE 215 Saudi Arabia anticoagulants market size, by drug class, 2021 - 2027 (USD Million) TABLE 216 Saudi Arabia anticoagulants market size, by route of administration, 2016 - 2020 (USD Million) TABLE 217 Saudi Arabia anticoagulants market size, by route of administration, 2021 - 2027 (USD Million) TABLE 218 Saudi Arabia anticoagulants market size, by application, 2016 - 2020 (USD Million) TABLE 219 Saudi Arabia anticoagulants market size, by application, 2021 - 2027 (USD Million) TABLE 220 Saudi Arabia anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million) TABLE 221 Saudi Arabia anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million) TABLE 222 UAE anticoagulants market size, by drug class, 2016 - 2020 (USD Million) TABLE 223 UAE anticoagulants market size, by drug class, 2021 - 2027 (USD Million) TABLE 224 UAE anticoagulants market size, by route of administration, 2016 - 2020 (USD Million) TABLE 225 UAE anticoagulants market size, by route of administration, 2021 - 2027 (USD Million) TABLE 226 UAE anticoagulants market size, by application, 2016 - 2020 (USD Million) TABLE 227 UAE anticoagulants market size, by application, 2021 - 2027 (USD Million) TABLE 228 UAE anticoagulants market size, by distribution channel, 2016 - 2020 (USD Million) TABLE 229 UAE anticoagulants market size, by distribution channel, 2021 - 2027 (USD Million) Charts & Figures FIG. 1 Top-down approach FIG. 2 Breakdown of primary participants FIG. 3 Anticoagulants industry 360 degree synopsis FIG. 4 Industry segmentation FIG. 5 Global anticoagulants market, 2016 - 2027 (USD Million) FIG. 6 Growth potential analysis, by drug class FIG. 7 Growth potential analysis, by route of administration FIG. 8 Growth potential analysis, by application FIG. 9 Growth potential analysis, by distribution channel FIG. 10 Porter's analysis FIG. 11 Company matrix analysis, 2019 FIG. 12 PESTEL analysis FIG. 13 Key segment trends, by drug class FIG. 14 Key segment trends, by route of administration FIG. 15 Key segment trends, by application FIG. 16 Key segment trends, by distribution channel FIG. 17 Key regional trends FIG. 18 Competitive dashboard, 2019

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:
Publisher: Global Market Insights, Inc.
Chat with us